Cardiogeni PLC (AQU:CGNI)
7.00
0.00 (0.00%)
At close: Sep 1, 2026
Cardiogeni Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 |
Cash & Equivalents | 0.08 | 0.33 | 0.17 | 2.12 | 3.15 |
Cash & Short-Term Investments | 0.08 | 0.33 | 0.17 | 2.12 | 3.15 |
Cash Growth | -74.56% | 96.02% | -91.97% | -32.92% | -43.54% |
Accounts Receivable | 0.03 | 0.02 | 0.02 | 0.08 | 0.01 |
Other Receivables | 0.32 | 0.27 | 0.35 | 0.79 | 2.2 |
Receivables | 0.35 | 0.29 | 0.37 | 0.87 | 2.22 |
Prepaid Expenses | - | - | - | 0.16 | 0.16 |
Total Current Assets | 0.43 | 0.62 | 0.54 | 3.15 | 5.54 |
Property, Plant & Equipment | 0.43 | 0.47 | 0.51 | 0.66 | 1.27 |
Long-Term Investments | -0 | - | - | - | - |
Other Intangible Assets | 0.61 | 0.67 | 0.67 | 1.18 | 1.33 |
Total Assets | 1.46 | 1.76 | 1.73 | 4.99 | 8.13 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 |
Accounts Payable | 0.14 | 0.27 | 0.27 | 0.12 | 0.24 |
Accrued Expenses | 0.35 | 0.69 | - | - | - |
Short-Term Debt | - | - | - | 0 | 0.01 |
Current Income Taxes Payable | - | 0 | 0.01 | 0.06 | 0.1 |
Current Unearned Revenue | - | - | - | 0.63 | 0.66 |
Other Current Liabilities | 0.1 | 0.2 | 1.08 | 0.59 | 0.87 |
Total Current Liabilities | 0.59 | 1.16 | 1.35 | 1.38 | 1.88 |
Long-Term Leases | - | - | - | 0.26 | 0.34 |
Long-Term Unearned Revenue | - | - | - | 9.38 | 10 |
Other Long-Term Liabilities | 0.04 | 7.11 | 7.13 | 0.08 | 0.06 |
Total Liabilities | 0.63 | 8.27 | 8.48 | 11.1 | 12.28 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 |
Common Stock | 0.85 | 0.06 | 0.06 | 0.06 | 0.06 |
Additional Paid-In Capital | 4.03 | 4.45 | 4.01 | 3.57 | 3.41 |
Retained Earnings | -5.97 | -23.11 | -22.69 | -21.8 | -19.67 |
Treasury Stock | -0.15 | -0.15 | -0.15 | -0.15 | -0.15 |
Comprehensive Income & Other | 2.06 | 12.24 | 12.02 | 12.21 | 12.2 |
Total Common Equity | 0.84 | -6.51 | -6.75 | -6.11 | -4.15 |
Minority Interest | -0 | -0 | -0 | - | - |
Shareholders' Equity | 0.83 | -6.51 | -6.75 | -6.11 | -4.15 |
Total Liabilities & Equity | 1.46 | 1.76 | 1.73 | 4.99 | 8.13 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 |
Total Debt | - | - | - | 0.26 | 0.35 |
Net Cash (Debt) | 0.08 | 0.33 | 0.17 | 1.85 | 2.81 |
Net Cash Growth | -74.56% | 96.02% | -90.82% | -34.04% | -49.76% |
Working Capital | -0.15 | -0.54 | -0.81 | 1.76 | 3.66 |
Tangible Book Value | 0.23 | -7.18 | -7.42 | -7.29 | -5.47 |
Land | 0.78 | 0.79 | - | - | - |
Machinery | 1.03 | 1.04 | - | 0.37 | 0.49 |
Leasehold Improvements | - | - | - | 0.5 | 0.5 |